94 related articles for article (PubMed ID: 2968274)
1. MPP+ depletes retinal dopamine and induces D-1 receptor supersensitivity.
Qu ZX; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1988 Apr; 148(3):453-5. PubMed ID: 2968274
[TBL] [Abstract][Full Text] [Related]
2. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
3. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
[TBL] [Abstract][Full Text] [Related]
5. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
Fuller RW; Hemrick-Luecke SK
Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601
[TBL] [Abstract][Full Text] [Related]
6. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Mytilineou C; Cohen G
J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
Chang GD; Ramirez VD
Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
[TBL] [Abstract][Full Text] [Related]
9. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
Jonsson G; Nwanze E; Luthman J; Sundström E
Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
[TBL] [Abstract][Full Text] [Related]
11. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
[TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine inhibits proton motive force in energized liver mitochondria.
Singh Y; Bhatnagar R; Sidhu GS; Batra JK; Krishna G
Arch Biochem Biophys; 1989 May; 271(1):217-22. PubMed ID: 2540715
[TBL] [Abstract][Full Text] [Related]
13. Central depletion of dopamine in rats by 1-methyl-4-phenylpyridine.
Okada M; Yokotani K; Yamashita M; Ikeda H; Osumi Y
Life Sci; 1989; 45(5):391-9. PubMed ID: 2788790
[TBL] [Abstract][Full Text] [Related]
14. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
[TBL] [Abstract][Full Text] [Related]
15. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
Sayre LM; Arora PK; Iacofano LA; Harik SI
Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
[TBL] [Abstract][Full Text] [Related]
16. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature.
Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Sep; 41(11):1415-24. PubMed ID: 3498107
[TBL] [Abstract][Full Text] [Related]
18. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
19. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles.
Sokol PP; Holohan PD; Ross CR
J Pharmacol Exp Ther; 1987 Jul; 242(1):152-7. PubMed ID: 2956410
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxic effect of 1-methyl-4-phenylpyridinium ion on dopaminergic neurons of the retina of goldfish.
Villani L; Poli A; Bissoli R; Barnabei O
Neurosci Lett; 1988 Mar; 86(2):167-72. PubMed ID: 3259300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
